Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neuroblastoma 3Glioblastoma 2Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Gliosarcoma 1Glioma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Choroid Plexus Carcinoma 1Brain Neoplasms 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 3AZD 6244 3fludarabine phosphate 2Specimen Handling 2Nivolumab 2Etoposide 2thymoglobulin 1pembrolizumab 1lorvotuzumab mertansine 1fludarabine 1X-Rays 1Trabectedin 1Thiotepa 1Tacrolimus 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy 1Photons 1Neurofibromin 1 1Mycophenolic Acid 1Mesna 1Melphalan 1Liquid Biopsy 1Ipilimumab 1Imatinib Mesylate 1Ifosfamide 1High-Energy Shock Waves 1Filgrastim 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibrosarcoma × Mycophenolic Acid × CNS × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡